Ignite Creation Date:
2025-12-24 @ 7:34 PM
Ignite Modification Date:
2025-12-26 @ 10:13 PM
Study NCT ID:
NCT06922903
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-04-13
First Post:
2025-04-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer.
Sponsor:
Yunhe Pharmaceutical (Tianjin) Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-04
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-05
Completion Date Type:
ESTIMATED
First Submit Date:
2025-04-03
First Submit QC Date:
None
Study First Post Date:
2025-04-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-09
Last Update Post Date:
2025-04-13
Last Update Post Date Type:
ACTUAL